症状性恶性多叶膜溢出复发的危险因素在患有可采取行动的突变的患者中是晚期肺腺癌
1Department of Respiratory and Critical Care Medicine, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
Translational lung cancer research
|October 19, 2023
概括
具有可起作用突变的患者患有较低恶性多流的复发. 向治疗和内管理有利于具有可操作突变的患者,改善无复发生存率.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 遗传学 是一个遗传学.
背景情况:
- 肺腺癌中恶性多流 (MPE) 与高死亡率和不良预后有关.
- 识别MPE复发的风险因素对于优化患者管理至关重要,特别是在突变流行率高的亚洲人群中.
研究的目的:
- 在患有肺腺癌的患者中调查恶性多叶流血复发的危险因素.
- 为了确定可操作的突变是否影响MPE复发和治疗策略.
主要方法:
- 对343名患有MPE的转移性肺腺癌患者的回顾性审查.
- 考克斯回归分析以确定MPE复发的独立风险因素,在初始胸腔切除后300天内.
主要成果:
- 在具有可操作突变的患者中,MPE复发发生在34.3%的患者中,而在没有MPE突变的患者中,复发发生在51.2%.
- 具有可操作突变的患者的复发风险显著降低 (RFS 中位数为 300 vs 161 天).
- 独立的保护因素包括30天内的向治疗,较低的中性粒细胞与淋巴细胞比率,较低的血清乳酸脱酶和较低的血清癌胚抗原.
结论:
- 可操作的突变与肺腺癌中MPE复发的风险较低有关.
- 向治疗和积极的内管理可以使可操作突变的患者受益,改善结果.
更多相关视频
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
8.0K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
476
相关概念视频
Pleural Effusion II: Symptoms and Management
188
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
188
Pleural Effusion I: Introduction
1.1K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.1K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
